Skip to main content
Premium Trial:

Request an Annual Quote

Sciona Relocates from UK to Colorado, Hires New CEO

NEW YORK, Jan. 25 (GenomeWeb News) - Sciona, a privately held firm developing DNA screens for nutrigenomics applications, has moved its headquarters from Havant, UK, to Boulder, Colo., the company said today.


Sciona has also appointed a new CEO, James Bruce, who most recently served as president and CEO of Madaus, a nutraceutical company.


The company's former CEO, Chris Martin, is now chairman of the board. He will continue to reside in the UK.


Sciona said it will employ a dozen people in Boulder and additional staff elsewhere in the UK, Italy, and the US, including an R&D lab on the YaleUniversity campus. Several of Sciona's UK employees will relocate to Boulder, including CTO Rosalynn Gill-Garrison, who will lead R&D activities.


Sciona currently markets the Cellf genetic screen, which provides nutritional guidelines for consumers based on their genetic profiles. The company also sells genetic screens in the areas of heart health, bone health, antioxidants and detoxification, immune response, and insulin sensitivity.

The Scan

Back as Director

A court has reinstated Nicole Boivin as director of the Max Planck Institute for the Science of Human History, Science reports.

Research, But Implementation?

Francis Collins reflects on his years as the director of the US National Institutes of Health with NPR.

For the False Negatives

The Guardian writes that the UK Health Security Agency is considering legal action against the lab that reported thousands of false negative COVID-19 test results.

Genome Biology Papers Present Epigenetics Benchmarking Resource, Genomic Architecture Maps of Peanuts, More

In Genome Biology this week: DNA methylation data for seven reference cell lines, three-dimensional genome architecture maps of peanut lines, and more.